2-methylazetidine-3-carbonitrile hydrochloride

Catalog No. :
ACUSBA416
CAS No. :
2231674-13-6
Molecular Formula :
C5H9ClN2
Molecular Weight :
132.59

IUPAC Name:2-methylazetidine-3-carbonitrile hydrochloride

2-methylazetidine-3-carbonitrile hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$400.00Login to see priceIn stockInquiry
250mg95%$641.00Login to see priceIn stockInquiry
500mg95%$1068.00Login to see priceIn stockInquiry
1g95%$1600.00Login to see priceIn stockInquiry
5g95%$4800.00Login to see priceInquiryInquiry
10g95%$7999.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-methylazetidine-3-carbonitrile hydrochloride
IUPAC Name2-methylazetidine-3-carbonitrile hydrochloride
MDL No.MFCD31705565
Molecular FormulaC5H9ClN2
Molecular Weight132.59
SMILESN#CC1C(C)NC1.[H]Cl
InChI KeyVWHFVCOSDXJTMD-UHFFFAOYSA-N
Synonym2231674-13-6 | 2-methylazetidine-3-carbonitrile hydrochloride | 2-methylazetidine-3-carbonitrile | hydrochloride | MFCD31705565 | 2-methylazetidine-3-carbonitrilehydrochloride | CS-0433443 | D96740
CAS No.2231674-13-6
PubChem CID135396232

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACUSBA416 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACUSBA416 route product structure diagram
    ACUSBA4162231674-13-6 In Stock
Inquiry

2. ACUSBA416 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACUSBA416 route product structure diagram
    ACUSBA4162231674-13-6 In Stock
Inquiry

Comments (0)